News
The Subject Expert Committee of India's Apex Drugs Authority Drugs Controller General of ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'The Subject Expert Committee of India's apex drugs authority Drugs Controller General of India has recommended permission for vaccine manufacturer @SerumInstIndia to conducting Phase 3 trial of #Covovax as booster dose in adults, said a source familiar with the development.'
The Subject Expert Committee of India's apex drugs authority Drugs Controller General of India has recommended permission for vaccine manufacturer @SerumInstIndia to conducting Phase 3 trial of #Covovax as booster dose in adults, said a source familiar with the development. pic.twitter.com/msygRMvFg8— IANS Tweets (@ians_india) March 6, 2022
(The above story first appeared on LatestLY on Mar 06, 2022 08:15 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
